A decision analysis for treatment of clinically localized prostate cancer

Journal of General Internal Medicine

Volumn 12, Issue 5, 1997, Pages 299-305

  Kattan, Michael W ^a   Cowen, Mark E ^b   Miles, Brian J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

decision analysis; patient derived utilities; prostate cancer; radical prostatectomy; watchful waiting

Indexed keywords

ARTICLE; CANCER GRADING; COMORBIDITY; HUMAN; MALE; MEDICAL DECISION MAKING; OBSERVATION; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; QUALITY ADJUSTED LIFE YEAR; SYSTEM ANALYSIS;

ADENOCARCINOMA; AGED; DECISION SUPPORT TECHNIQUES; HUMANS; LIFE EXPECTANCY; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0030993267     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1997.012005299.x     Document Type: Article

References (25)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45:8-30.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;65:5-27.
3. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548-52.
4. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242-8.
5. Gerber GS, Thisted RA, Chodak GW, et al. Results of radical prostatectomy in men with clinically localized prostate cancer: multiinstitutional analysis. J Urol. 1995;153:252A. Abstract 95.
6. Gerber GS, Thisted RA, Chodak GW, et al. Results of radical prostatectomy in men with clinically localized prostate cancer: multiinstitutional analysis. JAMA. 1996;276:615-9.
7. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995;274:626-31.
8. Fowler FJ, Wasson J, Barry MJ, Roman A, Lu-Yao G, Wennberg J. Effect of radical prostatectomy for prostate cancer on quality of life: results from a Medicare survey. Urology. 1995;45:1007-15.
9. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-35.
10. Cowen ME, Cahill D, Kattan MW, Miles BJ. The value or utility of prostate cancer states. J Urol. 1996;155:376A. Abstract 262.
11. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. for the Prostate Patient Outcomes Research Team. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650-8.
12. Beck JR, Kattan MW, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol. 1994;152:1894-9.
13. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am. 1993;20:713-25.
14. Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part 1: framing the debate. Urology. 1995;46:2-13.
15. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE. A structured literature review of treatment for localized prostate cancer. Arch Fam Med. 1993;2:487-93.
16. Eastham JA, Kattan MW, Goad JR, et al. Risk factors for urinary incontinence after radical retropubic prostatectomy. J Urol. 1996;156:1707-13.
17. Palapattu GS, Stapleton AMF, Seale-Hawkins CK, Kattan MW, Scardino PT. A change in the techniques of radical retropubic prostatectomy markedly improves postoperative potency. J Urol. 1996;155:647A. Abstract 1346.
18. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia, Pa: WB Saunders Co: 1980.
19. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res. Summer, 1972;7:118-33.
20. Froberg DG, Kane RL. Methodology for measuring health-state preferences, II: scaling methods. J Clin Epidemiol. 1989;42:459-71.
21. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam health outcomes study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89-102.
22. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decis Making. 1985;5:157-77.
23. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
24. Hynes LM, Littenberg B, Nease RF Jr. Experience with four utility-based measures of regret. Med Decis Making. 1995;15:424.
25. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. for the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and maintenance. JAMA. 1996;276:1171-7.